WVE-N531 Exon 53 Skipping Therapy for Duchenne Muscular Dystrophy: Open-Label Extension Study
Enrolling by InvitationPhase 2Exon Skipping
This information is provided for educational purposes only. Always consult the study investigators before making medical decisions.